Previous editions brought together Key Opinion Leaders from consortia, biotech, healthcare and large pharma for the Engager session, Accelerating Clinical Timelines: Using Ultra-Sensitive MRD to Accelerate Clinical Development, driving focused discussion on how MRD can meaningfully compress development timelines and sharpen trial decision making.

With limited capacity available, register your interest to attend today.